Patents by Inventor Paul Depledge

Paul Depledge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor necrosis factor antagonist
    Patent number: 5306732
    Abstract: Vinigrol or a pharmaceutically acceptable salt thereof is useful as a tumour necrosis factor antagonist. Vinigrol may therefore be used to treat endotoxic shock, inflammation, infection or cachexia.
    Type: Grant
    Filed: June 24, 1992
    Date of Patent: April 26, 1994
    Assignee: Xenova Limited
    Inventors: David B. Norris, Paul Depledge, Andrew P. Jackson